Angiotensin IV | CAS:202203-97-2

We serve Angiotensin IV CAS:202203-97-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Angiotensin IV

Chemical Name:Angiotensin IV
CAS.NO:202203-97-2
Synonyms:Angiotensin IV
L-Valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1189.7±65.0 °C at 760 mmHg
Molecular Formula C40H54N8O8
Molecular Weight 774.906
Flash Point 673.3±34.3 °C
Index of Refraction 1.601
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Angiotensin IV is a hexapeptide that, like angiotensin III, has some lesser activity. Angiotensin IV has a wide range of activities in the central nervous system.



Contact us for information like Angiotensin IV chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Angiotensin IV Use and application,L-Valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine technical grade,usp/ep/jp grade.


Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow.7-bromo-1-heptanol acetate manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide supplier Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.2-Nitroaminoimidazoline vendor The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.